M K Proteins logo

M K Proteins financials: balance sheet, profit and loss, cash flow

NSE: MKPLBSE: 543919Agricultural Food & other ProductsSmall Cap

M K Proteins Limited · Face value ₹1 · Listed Apr 2017 on NSE, Jun 2023 on BSE · Issue price ₹712
Last close ₹3.75up ₹0.05 (1.35%)BSE ₹3.80

Share price at the NSE close on 27 Oct 2026. Previous close ₹3.70.

27 Oct: open ₹3.76, high ₹3.81, low ₹3.66

52-week range of traded prices to 27 Oct 2026
₹3.56Low, 30 Mar 2026₹7.08High, 31 Oct 2025
Market cap
₹141 Cr2,433rd largest listed
P/E
29.96
P/B
1.84
Dividend yield
Nonein the last 12 months
ROE
6.4%
ROCE
7.1%
Debt to equity
0.47
Volume, NSE
46,05574.1% delivered

M K Proteins' financial statements for the 9 years to Mar 2026, standalone: the listed company alone, without its subsidiaries, with the twelve months to Jun 2026 after them.

9 years at a glance

₹ crore, years to March.M K Proteins annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
1721.4Mar 181571.6Mar 191941.8Mar 2031110Mar 2125610Mar 22Mar 232461119Mar 242688.438Mar 253836.836Mar 26
Peak revenue ₹383 Cr, year to Mar 2026; lowest ₹157 Cr, year to Mar 2019

Operating and net margin, per cent

  • Operating margin
  • Net margin
6.8%0.8%3.2%3.2%2.5%5.1%6.1%6.8%4.6%3.0%0.8%1.0%0.9%3.3%4.0%4.6%3.1%1.8%Mar 18Mar 20Mar 22Mar 24Mar 26

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 0.7% of operating profit in the first full year.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue383
  2. Materials and goods−353
  3. Employee costs−3.0
  4. Other expenses−15
  5. Operating profit11
  6. Depreciation−0.4
  7. Other income+0.3
  8. One-off items0.0
  9. Finance costs−1.9
  10. Profit before tax9.4
  11. Tax−2.6
  12. Net profit6.8

What the company owns

  • Inventory₹110 Cr
  • Plant, investments and other assets₹19 Cr
  • Receivables₹2 Cr
  • Cash and bank₹0 Cr

What pays for it: net worth and liabilities

  • Net worth₹76 Cr
  • Borrowings₹36 Cr
  • Other liabilities₹14 Cr
  • Owed to suppliers₹5 Cr

Profit and loss

Standalone, ₹ crore, years to March. No results on record for the year to Mar 2023. The last column is the twelve months to Jun 2026, the latest four quarters added.M K Proteins quarterly results

₹ croreMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 29 MayJun 2026Twelve monthsFiled 13 Aug
Revenue from operations172157194311256–246268383383
166152189295240–229255371375
Materials and goods bought158144180286227–216240353354
Employee costs22222–3333
Other expenses778811–10131518
Operating profit before depreciation6551616–1712118
Operating margin3.2%3.2%2.5%5.1%6.1%–6.8%4.6%3.0%2.2%
Materials, % of revenue92.0%91.6%92.7%91.9%88.8%–88.1%89.5%92.2%92.3%
Employee costs, % of revenue1.0%1.1%0.8%0.5%0.7%–1.1%1.0%0.8%0.9%
Other expenses, % of revenue3.8%4.2%4.0%2.5%4.4%–4.0%4.8%4.0%4.6%
Depreciation and amortisation11111–1000
Operating profit after depreciation4441515–1612118
Other income00000–0000
Finance costs22111–1122
One-off items00000–0000
Profit before tax2221414–151197
11144–4332
Net profit1221010–11875
Other comprehensive income––––––0000
Total comprehensive income––––––11875
Net margin0.8%1.0%0.9%3.3%4.0%–4.6%3.1%1.8%1.2%

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2024Mar 2025Mar 2026Filed 29 May
616976
Share capital383838
Reserves243239
193836
345953
122
Total assets96131131
101213
86119118
Net debt193836
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2018, Mar 2019, Mar 2020, Mar 2021 and Mar 2022, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2024Mar 2025Mar 2026Filed 29 May
32.4−16.15.4
35.9−11.98.0
20.0−24.4−3.4
Receivables12.82.2−0.7
Inventories−8.1−32.11.5
Payables6.77.8−14.3
Other working capital8.5−2.410.0
Tax paid−3.5−4.2−2.6
Capital spending5.92.21.9
Free cash flow26.5−18.43.5
−5.9−1.5−1.6
−26.517.6−3.4
Dividends paid0.00.00.0
Shares bought back0.00.00.0
Shares issued0.00.00.0
Net change in cash0.0−0.10.4
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2018, Mar 2019, Mar 2020, Mar 2021 and Mar 2022.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 29 May
Earnings per share––₹0.30₹0.22₹0.18
Diluted earnings per share––₹0.30₹0.22₹0.18
Book value per share––₹1.63₹1.85₹2.03
Shareholder yield––0.0%0.0%0.0%
Market cap at the year end (₹ crore)80–370226145

Ratios

Standalone, years to March.M K Proteins PE ratio and valuation

RatioMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 29 May
Revenue growth–−8.7%23.8%60.3%−17.7%––9.0%43.0%
Operating profit growth–−9.8%−3.7%232.6%−1.8%––−25.2%−8.2%
Net profit growth–15.2%10.6%471.8%−2.0%––−25.1%−18.7%
Earnings per share growth–––––––−26.7%−18.2%
––––––18.4%12.9%9.4%
–––––––−5.5 pts−3.5 pts
From the net margin–––––––−5.7 pts−5.6 pts
From asset turnover–––––––−0.9 pts1.8 pts
From borrowing–––––––1.2 pts0.3 pts
Return on capital employed––––––20.1%11.3%9.8%
Cash conversion––––––289.1%−192.1%79.6%
Interest cover2.02.42.420.017.7–15.110.95.9
Debt to equity––––––0.310.540.47
Receivable days––––––522
Inventory days––––––134170114
Payable days––––––19295
Cash conversion cycle, days––––––120142110
Working capital days––––––10513196
Asset turnover––––––2.552.362.93
Assets per rupee of net worth––––––1.581.741.80
Sales per rupee of plant––––––129.4693.6996.38
Capital spending to depreciation––––––11.176.324.34
Plant being built, % of plant in use––––––357.2%232.9%178.7%
No balance sheet is on record for the years to Mar 2018, Mar 2019, Mar 2020, Mar 2021 and Mar 2022, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
5.2%
Cash from operations against operating profit
47.6%
Measure5 years3 years
Revenue growth, yearly rate4.2%–
Profit growth, yearly rate−8.0%–
Return on equity, average–13.5%
Return on capital employed, average–13.7%
Operating margin, average5.1%4.8%
Net margin, average3.4%3.2%
Asset turnover, average–2.61
Cash conversion cycle, days, average–124
Interest cover, average12.410.7
Debt to equity, average–0.44

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore3 yearsLatest year
Cash from operations21.75.4
Cash from investing−9.0−1.6
Cash from financing−12.4−3.4
Capital spending10.01.9
Dividends paid0.00.0
Shares bought back0.00.0
Shares issued for cash0.00.0
Borrowings raised19.70.8
Borrowings repaid28.02.4

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––––––5
Altman Z-scorePublished threshold 1.81––––––10.425.485.80
Beneish M-scorePublished threshold −1.78–––––––−2.14−1.76
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets–––––––22.932.29
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––––0.82
Receivables growth less revenue growthOur threshold 0 percentage points–––––––−69.747.34
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––––––29.68−48.66
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––––––1.060.04
Assets under construction, years of additionsOur threshold 2 years of additions–––––––5.074.58
Effective tax ratePublished threshold 17.16 per cent35.2628.0925.6327.4627.47–27.5226.6727.26
Tax charged less tax paid, % of profitOur threshold 10 percentage points––––––4.81−9.970.03
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
5 Mar 2026CRISIL Ratings LimitedBank FacilitiesCrisil A-Review, DowngradeStable13
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.